Abstract
BackgroundLyme borreliosis is the most prevalent tick-borne disease in Europe. Ixodes ricinus also carries other pathogenic bacteria, but corresponding human diseases are rarely reported. Here, we compared the exposure to Rickettsia helvetica and Rickettsia monacensis with that to Lyme borreliosis spirochetes. We assumed that their exposure corresponds to their infection rate in questing I. ricinus.FindingsThree Rickettsia species were detected in ticks with a total prevalence of 7.9%, of which the majority was R. helvetica (78%) and R. monacensis (21%). From the same geographic area, skin biopsies of erythema migrans patients were investigated for possible co-infections with Rickettsia spp.. Forty-seven out of 67 skin biopsies were PCR positive for Borrelia burgdorferi s.l. and one sample was positive for R. monacensis. The Borrelia genospecies from the R. monacensis positive patient was identified as Borrelia afzelii. The patient did not show any symptoms associated with rickettsiosis.ConclusionsCo-infections of I. ricinus with Rickettsia spp. and B. burgdorferi s.l. were as high as expected from the individual prevalence of both pathogens. Co-infection rate in erythema migrans patients corresponded well with tick infection rates. To our knowledge, this is the first reported co-infection of B. afzelii and R. monacensis.
Highlights
Lyme borreliosis is the most prevalent tick-borne disease in Europe
Co-infections of I. ricinus with Rickettsia spp. and B. burgdorferi s.l. were as high as expected from the individual prevalence of both pathogens
Erythema migrans (EM) is an early sign of Lyme disease, which is caused by Borrelia burgdorferi sensu lato (s.l.) spirochetes that are transmitted by ticks
Summary
The co-infection rates in EM patients with Rickettsia spp. was as high as predicted by tick co-infection rates. All symptoms of the patient with R. monacensis coinfection can be explained by the B. afzelii infection and the virulence of this rickettsial agent remains unclear. This study highlights the importance of considering co-infections when treating Lyme borreliosis. Consent Informed written consent for publication was obtained from the parents of the patient. Competing interests The authors declare that they have no competing interests. Authors’ contributions NP and HS designed the study and NP collected samples and patient data. ETK carried out laboratory experiments and conducted data analysis. All authors contributed to the manuscript and approved the final version of the manuscript
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.